| Authors: |
Boerth JA; Medicinal Chemistry, Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States., Schimpl M; Protein, Structure and Biophysics, Discovery Sciences, R&D, AstraZeneca, Cambridge CB2 0AA, U.K., Lucas SCC; Hit Discovery, Discovery Sciences, R&D, AstraZeneca, Cambridge CB2 0AA, U.K., Zhang J; Bioscience, Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States., Code EL; Assays and Profiling, Discovery Sciences, R&D, AstraZeneca, Waltham, Massachusetts 02451, United States., Embrey KJ; New Modalities & Parenteral Development, PT&D, Operations, AstraZeneca, Macclesfield SK10 2NA, U.K., Rawlins PB; Protein, Structure and Biophysics, Discovery Sciences, R&D, AstraZeneca, Cambridge CB2 0AA, U.K., Wang H; Medicinal Chemistry, Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States., Storer RI; Hit Discovery, Discovery Sciences, R&D, AstraZeneca, Cambridge CB2 0AA, U.K., Di Fruscia P; Hit Discovery, Discovery Sciences, R&D, AstraZeneca, Cambridge CB2 0AA, U.K., Nelson JE; Hit Discovery, Discovery Sciences, R&D, AstraZeneca, Cambridge CB2 0AA, U.K., Milbradt AG; Mechanistic and Structural Biology, Discovery Sciences, R&D, AstraZeneca, Cambridge CB2 0AA, U.K., Börjesson U; Hit Discovery, Discovery Sciences, R&D, AstraZeneca, Gothenburg SE-43183, Sweden., Gohlke A; Protein, Structure and Biophysics, Discovery Sciences, R&D, AstraZeneca, Cambridge CB2 0AA, U.K., Korboukh V; Assays and Profiling, Discovery Sciences, R&D, AstraZeneca, Waltham, Massachusetts 02451, United States., Gopalsamy A; Medicinal Chemistry, Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States. |